With decades of experience representing multiple public companies across the entire spectrum of health care, Brian’s career
has spanned state, local, federal, and European governments, and is marked by creative public policy solutions that advance innovation, research, public health, and the pharmaceutical industry.

His career is marked by firsts. He invented state level vaccine mandates. He created intellectual property for re-purposed older drugs. He established a new CMS procedure for new drug codes. He effectively challenged FDA bio equivalency standards to insure patient safety and extend exclusivity. In a landmark case before the Securities and Exchange Commission, he changed the definition biotechnology companies to allow for more groundbreaking research investment. He changed the definition of mental health in state laws to allow for the coverage of medicines to treat depression. Most recently, he helped negotiate a groundbreaking agreement in the Medicare Drug Discount program.

He is the architect of four start from scratch, high performing, ROI focused Government Affairs Departments that have all produced Vice-Presidents/Head of GA functions for other public companies.

Brian founded the Personalized Medicine Coalition (PMC) in 2003 and remained on the Board of Directors for its first two decades. Dedicated to advancing personalized medicine, PMC aims to transform the way medicines are discovered, developed and delivered, facilitating a medical revolution based on the dreams and aspirations at the dawn of the humane genome era.

Brian also serves on the Board of Directors (Treasurer) of the Global Liver Institute, a health care non-profit organization dedicated to supporting liver disease patients and the broader liver health community.

Brian and his wife, Vicky, have four kids: Clay, Sophie, Jackson, and Aidan. They live in California and are frequent travelers to their longstanding community in Vienna, VA, outside Washington, DC.